Navigation Links
SleepQuest Compliance Again Doubles Industry Average
Date:2/3/2009

Study Shows Patients Consistently Adhere to Sleep Apnea Treatment

SAN CARLOS, Calif., Feb. 3 /PRNewswire/ -- SleepQuest announced today that an internal study has shown their patients comply with Obstructive Sleep Apnea treatment at a rate nearly twice the industry average.

Analysis performed in October 2008 looked at Northern California patients who received home sleep testing and treatment with Positive Airway Pressure beginning in early 2008. Of the patients surveyed, 91% were compliant, while known industry standards are closer to 50%. This percentage is based on the average number of treatment hours for patients using CPAP more than four hours per night.

"Compliance is dependent upon the caregiver's expertise with the many different complications that might occur with PAP treatment," said Robert Koenigsberg, SleepQuest President/CEO. "Our resolute focus is to troubleshoot problems that patients may experience and to find the right solutions for them."

Obstructive Sleep Apnea (OSA) is a dangerous condition in which soft tissues in the throat collapse during sleep, triggering a partial awakening to prevent suffocation. During PAP treatment (Continuous, Bi-level and AutoPAP), the patient receives positive air flow via a mask or nasal interface that keeps the airway open, allowing regular, quiet breathing and restful sleep to occur. Patients frequently have a hard time adjusting to treatment. Trial and error is often required to find the right combination of facial interface type, the most appropriate PAP device, and air flow settings that are most comfortable. If patients find it unpleasant, difficult to operate, or ineffective, they may lose interest in adhering to treatment.

"Most providers of CPAP therapy are general home care companies," said Lori Schulman, SleepQuest's Director of Contracting. "They focus on providing 1500 different products aimed at 150 different dise
'/>"/>

SOURCE SleepQuest
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. SleepQuest Achieves Coveted Accreditation
2. SleepQuest Tireless in Pursuit of Good Sleep
3. Latest Sleep Disorder Technology Tested With SleepQuest
4. SleepQuest to Open San Francisco Office
5. SleepQuest Raises Awareness of Sleep Disorders
6. SleepQuest Launches Updated Web Site
7. Level 3 Inspection Achieves 100% Compliance in ISO 9001 & AS 9100 Certification
8. Genesis Pharmaceuticals Appoints KPMG to Help Develop a SOX 404 Compliance Program
9. Verenium Regains Compliance With Nasdaq Continued Listing Requirement
10. MicroDose and Nexus6 Announce Collaboration to Evaluate Application of Remote Patient Compliance Monitoring Technology with MicroDoses Electronic Dry Powder Inhaler
11. NYSE Alternext US Accepts China Shenghuos Compliance Plan for Continued Listing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... LOUIS, July 30, 2015 HIGHLIGHTS:Q2 ... in 2014) , Reported sales were $697 million ... 2014.  Sales grew organically by 8%, and changes in ... acquisitions increased sales by 1%. , By business ... in Applied and 11% in SAFC Commercial. , ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... applications and designed for continuous operation up to 1500 bar. The sanitary design ... efficiency, and preventing toxic contamination. , The Pony™ NS2006L homogenizer is an ideal ...
(Date:7/29/2015)... According to a new market research report, ... , published by Mordor Intelligence, the Global market is expected ... 2020, with North America being the ... global market size. The Global market for Stem Cells is ... period of (2015-2020).      (Logo: http://photos.prnewswire.com/prnh/20150428/740799) , ...
(Date:7/29/2015)... 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ) today ... Financial Officer has resigned.  The Company has hired ... retired in December 2014, as full time interim CFO ... Andy Ashworth began his employment ... smooth transition.  Andy was the Company,s CFO from September ...
Breaking Biology Technology:Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 2Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 4Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 6Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 7Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 8Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 10Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 11Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 12Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 13Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 14Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 15Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 16Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 17Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 18Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 19Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 20GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 2Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 3BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3
... , The enzyme DFPase from the squid ... efficiently detoxify chemical warfare agents such as Sarin, which ... A detailed understanding ,of the mechanism by which enzymes ... improve their properties. A group of ,researchers at the ...
... can estimate the origin and time of an aerosolized ... the first few cases has been developed by researchers ... Analysis and Modelling at Imperial College London in collaboration ... , The method, described in an article published ...
... in key leadership expertise to strengthen its European business ... SIRO ClinPharm Pvt. Ltd., a leading multinational full ... of Scott L. Spector as President Strategic Operations Europe. ... office of Omega Mediation . Mr. Spector brings ...
Cached Biology Technology:Structure of enzyme against chemical warfare agents determined 2Novel method predicts impact of a covert anthrax release 2SIRO Group Appoints Scott L. Spector as President, Strategic Operations, for its European Business 2
(Date:6/25/2015)...  TAKE Solutions Ltd., a global business technology solutions ... Patent and Trademark Office (USPTO) for its "Method for ... Clinical Accelerators to reduce the time taken to standardize ... without the accelerators), thus reducing time to market. ... the heart of the patented Clinical Data Standardization Process ...
(Date:6/24/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), ... announced that Sharp has selected its industry-leading Natural ... its latest flagship smartphone device, the AQUOS ZETA ... shipments of its fingerprint ID sensor technology, this ... and leadership in the biometrics market through its ...
(Date:6/23/2015)... , June 23, 2015   MedNet Solutions ... supports the entire spectrum of clinical research, is ... ™ , the company,s intuitive, flexible and ... a Silver 2015 Stevie® Award by the ... & Services Website category.  The American Business Awards ...
Breaking Biology News(10 mins):TAKE Solutions Awarded Patent By USPTO 2Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2
... Research Institute (NHGRI), one of the National Institutes ... Sequencing Research Network will begin sequencing 12 more ... and several important insects, as part of its ... genome. , The National Advisory Council for Human ...
... a marvel of versatility, creating a variety of cells that ... out these tasks, immune cells follow a career path that ... in the May 2005 issue of Immunity, Fox Chase Cancer ... Dietmar J. Kappes, Ph.D., show that cell-receptor signaling strength influences ...
... the biological literature resides in full text articles, instead ... publicly available literature data mining tools. Most literature mining ... extracted from curated gene or protein databases. This is ... the many name variants which are used to refer ...
Cached Biology News:NHGRI targets 12 more organisms for genome sequencing 2NHGRI targets 12 more organisms for genome sequencing 3NHGRI targets 12 more organisms for genome sequencing 4NHGRI targets 12 more organisms for genome sequencing 5Fox Chase study shows that weakened T-cell receptor signals change T-cell lineage 2Fox Chase study shows that weakened T-cell receptor signals change T-cell lineage 3